| 产品描述: | KW-8232 free base是一种具有口服活性的抗骨质疏松剂,可以减少前列腺素 PGE2 的生物合成。 |
| 靶点: |
Prostaglandin Receptor |
| 体外研究: |
KW-8232 is an anti-osteoporotic agent. KW-8232 reduces the biosynthesis of PGE2 in mouse osteoblastic cells. KW-8232 possesses anti-viral activity against SARS-CoV-2 (EC50 ~1.2 μM ). |
| 体内研究: |
KW-8232 (3, 10, 30 mg/kg, p.o.) potently increases the femoral bone mineral density (BMD) of immobilized legs of rats, and affects immobilization-induced abnormal bone turnovrer. KW-8232 markedly decreases urinary calcium excreation in the neurectomized r 웿 Ů ñ 샮㡽䇘睜⪰ޏࠃ 䇩睜 䇩睜Ȃ Ӥ 晐睦Ӥ 晐睦Ӥ 峀睜 弴睜 ڤ 犐ƈ ڤ郥댻嬧睜Ӥ 乨Ƥ鄩댻婯睜Љ �ޝ乜Ƥ媜睜 Ӥ ItemҮ쎾番莰ଁ뢜సങ獲䥷唍హ ⻌హ�唒⸼హ ଁ 敖ﰨ 唎ъ ﰰ |
| 参考文献: |
1. Uchii M, et al. Effect of KW-8232, a novel anti-osteoporotic agent, on bone loss in sciatic neurectomized rats. Jpn J Pharmacol. 1998 Oct;78(2):241-3.
|
| 保存条件: |
-20°C |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
1.642 ml |
8.208 ml |
16.416 ml |
| 5 mM |
0.328 ml |
1.642 ml |
3.283 ml |
| 10 mM |
0.164 ml |
0.821 ml |
1.642 ml |
| 50 mM |
0.033 ml |
0.164 ml |
0.328 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |